These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26225260)

  • 1. Resistance Development: A Major Piece in the Jigsaw Puzzle of Tumor Size Modeling.
    Terranova N; Girard P; Klinkhardt U; Munafo A
    CPT Pharmacometrics Syst Pharmacol; 2015 Jun; 4(6):320-3. PubMed ID: 26225260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patients.
    Claret L; Mercier F; Houk BE; Milligan PA; Bruno R
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):567-73. PubMed ID: 26198314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGI-Simulator: a visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug.
    Terranova N; Magni P
    Comput Methods Programs Biomed; 2012 Feb; 105(2):162-74. PubMed ID: 22005012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.
    Claret L; Girard P; Hoff PM; Van Cutsem E; Zuideveld KP; Jorga K; Fagerberg J; Bruno R
    J Clin Oncol; 2009 Sep; 27(25):4103-8. PubMed ID: 19636014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mathematical models to understand anticancer drug delivery and its effect on solid tumors.
    Li C; Krishnan J; Stebbing J; Xu XY
    Pharmacogenomics; 2011 Sep; 12(9):1337-48. PubMed ID: 21919608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solving Square Jigsaw Puzzle by Hierarchical Loop Constraints.
    Son K; Hays J; Cooper DB
    IEEE Trans Pattern Anal Mach Intell; 2019 Sep; 41(9):2222-2235. PubMed ID: 30028692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development.
    Bernard A; Kimko H; Mital D; Poggesi I
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1057-69. PubMed ID: 22632710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling systems-level dynamics: Understanding without mechanistic explanation in integrative systems biology.
    MacLeod M; Nersessian NJ
    Stud Hist Philos Biol Biomed Sci; 2015 Feb; 49():1-11. PubMed ID: 25462871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children with Prader-Willi syndrome vs. Williams syndrome: indirect effects on parents during a jigsaw puzzle task.
    Ly TM; Hodapp RM
    J Intellect Disabil Res; 2005 Dec; 49(Pt 12):929-39. PubMed ID: 16287481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of targeted and cytotoxic agents in murine subcutaneous tumor models correlates with clinical response.
    Wong H; Choo EF; Alicke B; Ding X; La H; McNamara E; Theil FP; Tibbitts J; Friedman LS; Hop CE; Gould SE
    Clin Cancer Res; 2012 Jul; 18(14):3846-55. PubMed ID: 22648270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.
    Levasseur LM; Slocum HK; Rustum YM; Greco WR
    Cancer Res; 1998 Dec; 58(24):5749-61. PubMed ID: 9865733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modeling of the coating process.
    Toschkoff G; Khinast JG
    Int J Pharm; 2013 Dec; 457(2):407-22. PubMed ID: 23988564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.
    Popilski H; Stepensky D
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):767-84. PubMed ID: 25813659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
    Yamazaki S; Spilker ME; Vicini P
    Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems Medicine in Pharmaceutical Research and Development.
    Kuepfer L; Schuppert A
    Methods Mol Biol; 2016; 1386():87-104. PubMed ID: 26677181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mathematical modeling of life history evolution: a brief history and main trends].
    Budilova EV; Terekhin AT
    Zh Obshch Biol; 2010; 71(4):275-86. PubMed ID: 20865929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of time perception in young and elderly people during jigsaw puzzle tasks with different complexities.
    Iwamoto Y; Hoshiyama M
    Occup Ther Int; 2011 Dec; 18(4):194-200. PubMed ID: 21721064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.